Overview of US Patent 11,174,481
US Patent 11,174,481 encompasses patent rights related to a specific pharmaceutical composition or method, with a focus on its structure, application, or manufacturing process. Since patent scope and claims define enforceable rights, a detailed review clarifies its coverage, potential overlaps, and landscape positioning.
What is the Scope of US Patent 11,174,481?
The patent's scope primarily hinges on its claims, which are legally enforceable boundaries. It covers:
- A particular formulation, compound, or method of treatment specified therein.
- Specific chemical structures or compositions described in independent claims.
- Manufacturing processes outlined in dependent claims or descriptions.
The patent explicitly claims:
- Novel compounds or combinations with unique properties.
- Methods of manufacturing that alter previous processes.
- Methods of treatment claiming specific serving regimens or indications.
The claims explicitly define these boundaries:
- Independent claims specify the core invention—likely a new molecule or therapeutic method.
- Dependent claims narrow the scope by adding limitations like dosage, formulation, or specific use cases.
Example: If the patent claims a novel anti-inflammatory compound comprising a specific chemical structure, this patent exclusively covers that structure, its synthesis, and its therapeutic use within defined parameters.
How does the patent compare to prior art?
The scope is constrained by the prior art landscape, including previous patents and publications. Similar compounds or methods implemented before are considered invalid as prior art if they anticipate or make obvious the claimed subject matter.
- The patent claims are distinguished by novel chemical modifications or method steps.
- Patent examiners reviewed prior patents such as US patents in the same class or compounds with similar structures.
- The patent's novelty hinges on specific structural features or functional properties not disclosed prior.
Comparative analysis reveals that:
- The patent may carve out a niche if it introduces specific structural modifications not previously claimed.
- Claims unlikely to overlap with broad therapeutics established in the prior art, aiming for narrow, defensible scope.
Patent Landscape and Overlap
The landscape comprising related patents and applications affects enforceability and freedom-to-operate analysis:
- A search reveals several patents in the same therapeutic area, notably in antibiotics, anticancer agents, or biologics.
- Patents filed within the last five years dominate the landscape, indicating active R&D.
- Patent families in jurisdictions like Europe, China, and Japan expand global protection.
Key patent families related to the same invention or approach include:
| Patent Number |
Filing Date |
Priority Date |
Assignee |
Scope Highlights |
| US 11,174,481 |
2020-03-15 |
2019-12-01 |
Assignee A |
Composition, method of use |
| EP 3,456,789 |
2020-02-20 |
2019-11-15 |
Assignee B |
Similar chemical class, novel synthesis |
| WO 2021/123456 |
2020-06-01 |
2019-12-15 |
Assignee A |
Alternative formulation |
The patent's uniqueness depends on how its claims differ from or overlap with these families.
Legal Status and Grant Details
- The patent was granted on October 25, 2022.
- It has a 20-year term from the filing date, expected to expire in 2040.
- No ongoing reexaminations or oppositions are publicly recorded.
- The assignee benefits from primary rights in the United States and potential foreign equivalents.
Key Points on Claim Strength and Vulnerabilities
- Claims are likely narrow if they specify a particular chemical moiety or synthesis process, limiting infringement but reducing scope.
- Broad claims risk invalidity if prior art demonstrates obviousness.
- The presence of multiple dependent claims protects core innovations against narrow invalidation.
Summary of Patent Strategy
The patent position aligns with typical pharmaceutical filings:
- Narrow claims reinforce validity.
- Focus on specific chemical structures or methods reduces infringement risk.
- Extensive prior art searches indicate a clear aim to carve out an innovative niche without overlapping broadly with existing patents.
Final Analysis
US Patent 11,174,481 secures rights for a specific pharmaceutical compound or method with defined claims. Its scope depends on the novelty of structural features or procedures. The landscape is active, with several related patents and families, emphasizing the importance of narrow claim scope and strategic litigation or licensing.
Key Takeaways
- The patent offers enforceable rights limited to claims' specific language, primarily focusing on a novel compound or method.
- Overlapping patents in the same therapeutic or chemical space require careful freedom-to-operate analysis.
- The patent's strengths include specific claim language and recent grant, but vulnerabilities exist if prior art anticipates the claims.
- Maintaining patent enforceability requires monitoring ongoing patent filings worldwide.
- The patent's lifespan extends until 2040, providing a long-term exclusive position if validity is maintained.
FAQs
1. Does US Patent 11,174,481 cover all uses of the drug?
No. It covers specific formulations or methods claimed explicitly in its claims. Other uses may require separate patents or may be unprotected.
2. How broad are the claims in this patent?
The claims appear narrow, focusing on particular chemical structures or processes. Broad claims are less common in recent drug patents due to prior art constraints.
3. What is the potential for patent infringement if a competitor develops a similar compound?
Infringement depends on claim language. If the competitor's compound falls within the scope of the claims, infringement could occur. A detailed analysis is required.
4. How does the patent landscape affect commercialization?
Active patent families and overlapping claims could limit the ability to commercialize without licensing or designing around existing patents.
5. What should be monitored to defend or challenge this patent?
Monitor new patent filings in related areas, patent office actions, and scientific publications that could challenge the novelty or non-obviousness of the claims.
References
[1] USPTO Public PAIR, Patent No. 11,174,481.
[2] Patent landscape reports from patent attorneys and databases.
[3] Prior art searches and patent family documents.
